{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.36","upperLimit":"40.84","value":"33.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"}],"units":"Participants"}],"description":"Tumor response by imaging. Complete Response (CR): Complete disappearance of the tumor. Partial Response (PR): At least 64% decrease in volume compared to the measurement obtained at study enrollment. Overall Response (OR)=CR+PR.","dispersionType":"95% Confidence Interval","groups":[{"description":"Intermediate \\& High Risk; Neoadjuvant chemoradiotherapy","id":"OG000","title":"Arm D"}],"paramType":"NUMBER","populationDescription":"Only Arm D patients were evaluated for imaging response at week 13 after surgery. Ineligible and inevaluable Arm D patients were excluded.","reportingStatus":"POSTED","timeFrame":"13 weeks","title":"Complete or Partial Response Rate","type":"SECONDARY","unitOfMeasure":"percentage of patients"}